Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019

Amphastar Pharma (AMPH) Tops Q3 EPS by 3c

November 7, 2019 4:41 PM EST

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the quarter came in at $80.1 million versus the consensus estimate of $78.53 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

... More